Citius Oncology (CTOR) Deferred Taxes (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Deferred Taxes of -$231210.0 for Q1 2026, down 187.5% year-over-year from $264240.0 in Q1 2025, and down 187.5% quarter-over-quarter from $264240.0 in Q4 2025.
Citius Oncology (CTOR) Deferred Taxes (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Deferred Taxes for 4 consecutive years, with -$231210.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes fell 187.5% year-over-year to -$231210.0; the TTM figure through Mar 2026 stood at $561510.0 (down 55.02% YoY), while the FY2025 annual figure was $1.1 million, up 83.5% from the prior year.
- Deferred Taxes slipped to -$231210.0 in Q1 2026 per CTOR's latest filing, from $264240.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $432000.0 in Q2 2024 and bottomed at -$231210.0 in Q1 2026.
- Historically, Deferred Taxes has averaged $217110.0 across 4 years, with a median of $264240.0 in 2024.
- Annual changes were most pronounced in 2024 — Deferred Taxes jumped 83.5% — and 2026, when it sank 187.5%.
- Citius Oncology's Deferred Taxes stood at $144000.0 in 2023, then surged by 83.5% to $264240.0 in 2024, then changed by 0.0% to $264240.0 in 2025, then tumbled by 187.5% to -$231210.0 in 2026.
- Business Quant data shows CTOR's Deferred Taxes at -$231210.0 in Q1 2026, $264240.0 in Q4 2025, and $264240.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | -107,347.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231,210.00 |
| Dec 31, 2025 | 264,240.00 |
| Sep 30, 2025 | 264,240.00 |
| Jun 30, 2025 | 264,240.00 |
| Mar 31, 2025 | 264,240.00 |
| Dec 31, 2024 | 264,240.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 288,000.00 |
| Dec 31, 2023 | 144,000.00 |